Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 30, 2016 | $64.9B |
| FY2017, ended Oct 29, 2017 | $103B |
| FY2018, ended Nov 4, 2018 | $89.9B |
| FY2019, ended Nov 3, 2019 | $118B |
| FY2020, ended Nov 1, 2020 | $142B |
| FY2021, ended Oct 31, 2021 | $220B |
| FY2022, ended Oct 30, 2022 | $198B |
| FY2023, ended Oct 29, 2023 | $392B |
| FY2024, ended Nov 3, 2024 | $792B |
| FY2025, ended Nov 2, 2025 | $1.75T |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $1.86T |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 30, 2016 | $13.2B |
| FY2017, ended Oct 29, 2017 | $17.6B |
| FY2018, ended Nov 4, 2018 | $20.8B |
| FY2019, ended Nov 3, 2019 | $22.6B |
| FY2020, ended Nov 1, 2020 | $23.9B |
| FY2021, ended Oct 31, 2021 | $27.4B |
| FY2022, ended Oct 30, 2022 | $33.2B |
| FY2023, ended Oct 29, 2023 | $35.8B |
| FY2024, ended Nov 3, 2024 | $51.6B |
| FY2025, ended Nov 2, 2025 | $63.9B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $89.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 30, 2016 | −$1.74B | $2.69B |
| FY2017, ended Oct 29, 2017 | $1.69B | $5.48B |
| FY2018, ended Nov 4, 2018 | $12.3B | $8.24B |
| FY2019, ended Nov 3, 2019 | $2.69B | $9.27B |
| FY2020, ended Nov 1, 2020 | $2.66B | $11.6B |
| FY2021, ended Oct 31, 2021 | $6.44B | $13.3B |
| FY2022, ended Oct 30, 2022 | $11.5B | $16.3B |
| FY2023, ended Oct 29, 2023 | $14.1B | $17.6B |
| FY2024, ended Nov 3, 2024 | $5.89B | $19.4B |
| FY2025, ended Nov 2, 2025 | $23.1B | $26.9B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $38.3B | $39.4B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 30, 2016 | $3.10B |
| FY2017, ended Oct 29, 2017 | $11.2B |
| FY2018, ended Nov 4, 2018 | $4.29B |
| FY2019, ended Nov 3, 2019 | $5.05B |
| FY2020, ended Nov 1, 2020 | $7.62B |
| FY2021, ended Oct 31, 2021 | $12.2B |
| FY2022, ended Oct 30, 2022 | $12.4B |
| FY2023, ended Oct 29, 2023 | $14.2B |
| FY2024, ended Nov 3, 2024 | $9.35B |
| FY2025, ended Nov 2, 2025 | $16.2B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $24.0B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 30, 2016 | — |
| FY2017, ended Oct 29, 2017 | $17.5B |
| FY2018, ended Nov 4, 2018 | $17.5B |
| FY2019, ended Nov 3, 2019 | $32.8B |
| FY2020, ended Nov 1, 2020 | $41.0B |
| FY2021, ended Oct 31, 2021 | $39.7B |
| FY2022, ended Oct 30, 2022 | $39.5B |
| FY2023, ended Oct 29, 2023 | $39.2B |
| FY2024, ended Nov 3, 2024 | $67.6B |
| FY2025, ended Nov 2, 2025 | $65.1B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $59.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 24.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 30, 2016 | 3.83B |
| FY2017, ended Oct 29, 2017 | 4.09B |
| FY2018, ended Nov 4, 2018 | 4.07B |
| FY2019, ended Nov 3, 2019 | 3.98B |
| FY2020, ended Nov 1, 2020 | 4.07B |
| FY2021, ended Oct 31, 2021 | 4.13B |
| FY2022, ended Oct 30, 2022 | 4.18B |
| FY2023, ended Oct 29, 2023 | 4.68B |
| FY2024, ended Nov 3, 2024 | 4.69B |
| FY2025, ended Nov 2, 2025 | 4.74B |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | 4.77B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Oct 30, 2016 | $0 | $679M | — | — |
| FY2017, ended Oct 29, 2017 | $0 | $921M | $257M | — |
| FY2018, ended Nov 4, 2018 | $7.26B | $1.23B | $212M | — |
| FY2019, ended Nov 3, 2019 | $5.43B | $2.19B | $253M | — |
| FY2020, ended Nov 1, 2020 | $0 | $1.98B | $276M | — |
| FY2021, ended Oct 31, 2021 | $0 | $1.70B | $170M | — |
| FY2022, ended Oct 30, 2022 | $7.00B | $1.53B | $114M | — |
| FY2023, ended Oct 29, 2023 | $5.82B | $2.17B | $122M | — |
| FY2024, ended Nov 3, 2024 | $7.18B | $5.74B | $190M | $53.4B |
| FY2025, ended Nov 2, 2025 | $2.45B | $7.57B | $221M | — |
| Trailing 12 months to Aug 2, 2026 (through Q3 FY2026) | $8.45B | $8.48B | $216M | — |
Valuation
At current price- Market Cap
- $1.63T
- P/E
- 42.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 18.3×
- Price / Book
- 16.4×
- EV / EBITDA
- 32.5×
Growth
Trailing 12 months- Revenue (TTM)
- $89.1B
- Revenue Growth YoY
- 48.7%
- Revenue CAGR 3Y
- 24.4%
- Revenue CAGR 5Y
- 21.7%
- EPS Growth YoY
- 100%
- Net Income Growth YoY
- 102%
Profitability
Trailing 12 months- Gross Margin
- 68.8%
- Operating Margin
- 48.0%
- Net Margin
- 42.9%
- FCF Margin
- 44.2%
- Return on Equity
- 44.2%
Earnings
Trailing 12 months- Net Income
- $38.3B
- EPS (diluted)
- $7.84
- EBITDA
- $51.4B
- Operating Income
- $42.8B
Balance Sheet
As of Aug 2, 2026- Cash and cash equivalents
- $24.0B
- Total Debt
- $59.4B
- Net Debt
- $35.4B
- Total Assets
- $188B
- Total Liabilities
- $88.5B
- Shareholders' Equity
- $99.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $40.7B
- Capital Expenditure
- $1.25B
- Free Cash Flow
- $39.4B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $2.60
- Beta (5Y)
- 1.46
Every ratio is calculated from the company’s reported figures.